Single nucleotide polymorphisms in type A c-aminobutyric acid (GABA A ) receptor b 2 subunit gene (GABRB2) were found to be associated with schizophrenia in Chinese, German, Japanese and Portuguese. To explore potential functional consequences of these DNA sequence polymorphisms, this study examined the expression and electrophysiological properties of two alternatively spliced products of GABRB2 along with genotypical disease association analysis. Real-time quantitative polymerase chain reaction, performed with a cohort of 31 schizophrenics and 31 controls of US population, showed 21.7% reduction in the expression of the long isoform b 2L , 13.4% in the short isoform b 2S and 15.8% in the sum of the two isoforms b 2T in postmortem schizophrenic brain. Furthermore, two independent mRNA quantitation methods showed that the relative expression of the long over the short isoforms was significantly decreased, suggesting the occurrence of altered splicing, in schizophrenia. In male schizophrenics, the heterozygous genotypes of rs1876071 (T/C) and rs1876072 (A/G) were correlated with reduced expression of b 2L , b 2S and b 2T , and the heterozygous of rs2546620 (A/G) and homozygous-minor of rs1876071 (C/C) and rs1876072 (G/G) were correlated with reduced expression of b 2T . Significant correlations of expression levels with different alleles and haplotypes were also indicated by quantitative trait analysis. Recombinant GABA A receptors expressed in HEK293 human cells containing b 2L underwent a steeper current rundown upon repetitive GABA activation than receptors containing b 2S . The results thus revealed genotype-dependent expression of the alternatively spliced isoforms of GABA A receptor b 2 subunit, giving rise to electrophysiological consequences that could play an important role in the pathogenesis mechanism of schizophrenia.
Introduction
Schizophrenia is a complex psychiatric disorder with a strong genetic component. Recent advances in population and family-based association analysis have led to the discovery of a number of candidate genes for schizophrenia. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] For one of them, the GABRB2 gene, our earlier finding of an association between schizophrenia and single nucleotide polymorphisms (SNPs) and haplotypes in introns 8 and 9 among Han Chinese 1 has since been validated for German, Portuguese, Japanese as well as additional Chinese subjects. 2, [18] [19] [20] However, it is as yet unclear how the genotypic variations of this candidate schizophrenic gene would generate cellular changes pertinent to the pathogenesis of the disease.
g-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the vertebrate nervous system, where a fast synaptic inhibition is mediated by the opening of a chloride channel formed by the GABA A receptor. GABA A receptors contain the sites of action of several clinically important ligands including barbiturates and benzodiazepine anxiolytics. 21, 22 Subtypes of GABA A receptors are assembled from pentameric combinations of a 1 -a 6 , b 1 -b 3 , g 1 -g 3 , r 1 -r 3 , y, e, d and p subunits. 21, 22 Among them, a 1 , b 2 and g 2 constitute the principal components of most GABA A receptors. 23 The b 2 subunit is found in two alternatively spliced isoforms, the short isoform b 2S and the long isoform b 2L . 24 The long isoform contains an extra 38-amino-acid long Exon 10, which harbors a consensus sequence for phosphorylation by calmodulin-dependent protein kinase II. GABRB2 is abundant in the gray matter, but undetectable in the white matter of human brain. 25 Postmortem schizophrenic brain samples exhibit a spectrum of alterations with respect to GABA A receptor binding, 26 a 1 , a 6 , g 2 and d subunit mRNA levels, 2, [27] [28] [29] and a 1 , b 1 , b 2/3 and g subunit protein expression. 25, 30 Changes in the expression of the b 2/3 subunits in schizophrenic and bipolar subjects were observed immunochemically, even though the antibodies employed did not allow distinction between the b 2 and b 3 subunits, 25 but in situ hybridization did not show any significant difference between schizophrenics and controls in b 2 subunit mRNA expression. 31 So far there has been no study of the relative expression of the two alternatively spliced isoforms of the b 2 subunit in schizophrenia.
As the SNPs in GABRB2 associated with schizophrenia are located in non-coding regions, 1 potential consequences of their genotypic variations on the relative expression of the alternatively spliced isoforms merit close scrutiny. Accordingly, in the present study postmortem brain samples from the dorsolateral prefrontal cortex (DLPFC), where prominent functional and neuroanatomical abnormalities are encountered in psychiatric diseases, 32, 33 were examined to detect any changes in the mRNAs of the two isoforms using quantitative polymerase chain reaction (qPCR) and capillary electrophoresis of fluorescence-labeled reverse transcription-polymerase chain reaction (RT-PCR) product (CE), and to delineate possible relationships between such changes and DNA sequence polymorphisms. Electrophysiological differences between GABA A receptors containing the two isoforms with regard to current rundowns induced by repeated activation were also investigated using transfected human embryonic kidney (HEK293) cells expressing recombinant receptors.
Materials and methods
DNA and RNA samples DNA and RNA samples extracted from postmortem DLPFC gray matters (Brodmann's area 46) were donated by the Stanley Array Collection. 34 These samples were collected from 31 schizophrenic patients and 31 controls without any history of psychiatric or neurological disorders (Table 1) . Diagnoses were made according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (American Psychiatric Association).
Oligonucleotide primers and probes
The primers for PCR and DNA sequencing, and probes of the short isoform b 2S , the sum of the two isoforms b 2T , and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for qPCR were designed using Primer Express 3.0 (Applied Biosystems Inc., Foster City, CA, USA), as detailed in Supplementary Samples from 35 controls and 35 schizophrenics were received and four from each group giving no RT-PCR products were excluded from this study.
Two isoforms of GABRB2 in schizophrenia C Zhao et al and were supplied by Proligo Singapore Pte Ltd (Singapore). The specificity of each primer was validated against the human genome database of National Center for Biotechnology Information by means of BLASTN, and the fidelity of PCR amplicons was verified by agarose gel electrophoresis and DNA sequencing. TaqMan Expression Assays (Applied Biosystems) were used for the long form b 2L , Ubiquitin C (UBC) and Hydroxymethyl-bilane synthase (HMBS).
PCR amplification of targeted genomic region The 3.89-kb genomic region examined spanned from 2187 bp upstream to 1453 bp downstream of Exon 9 of GABRB2, which harbored the schizophrenia-associated SNPs reported previously. 1 PCR amplification of DNA fragments was performed in a 20-ml mixture containing 10 ng genomic DNA, 75 nM of each of the primers, 50 nM of each dNTP, 2.5 mM MgCl 2 and 1 U Taq DNA polymerase (Amersham, Uppsala, Sweden). PCR reaction consisted of initial denaturation at 941C for 5 min, 35 cycles each of 30 s at 951C, 30 s at 601C and 2 min at 721C, plus a final extension step at 721C for 5 min. The PCR products were resolved on 1.0% agarose gels, and stained with ethidium bromide to confirm the presence of products of expected sizes and absence of nonspecific products. To purify the PCR products, absolute ethanol was added to the mixture to a final concentration of 75%, and the mixture was kept at 41C for at least 1 h. After centrifugation at 3000 r.p.m. for 30 min at room temperature, the precipitates were washed three times with 70% ethanol, with centrifugation between washes at 4000 r.p.m. for 15 min at room temperature. The air-dried PCR product precipitates were dissolved in 1 Â TE buffer for use in subsequent sequencing reactions.
DNA sequencing of PCR products
Both SNP discovery and genotyping were accomplished by direct sequencing of PCR products as described. 1 Each sequencing reaction contained 0.5 ml of BigDye Terminator version 3.1 (Applied Biosystems), B100 ng purified PCR products and 1 mM sequencing primer. Each cycle of sequencing reaction consisted of initial denaturation at 961C for 1 min, followed by 25 cycles each of 10 s at 961C, 5 s at 501C and 4 min at 601C. Ethanol precipitation was employed to clean-up the post-sequencing mixture as described for the PCR products. Each air-dried sequencing sample was dissolved in 10 ml Hi-Deionized formamide, denatured at 951C for 1 min, and immediately chilled to 41C before sequencing with a Model 3130 Genetic Analyzer (Applied Biosystems).
Sequence chromatogram alignment-based SNP discovery and genotype calling were carried out using the software package PolyPhred version 4.2. 35 All genotype results were manually confirmed by at least two independent researchers. Most of the SNPs analyzed fell within the high-quality region (Quality Value X20), and all occasional low-quality passes were re-sequenced. In the first method, reverse transcription was performed to generate cDNA template for qPCR. Reaction was carried out with 2 mg of total RNA, random hexamers and TaqMan Reverse Transcription Kit (Applied Biosystems) for 10 min at 251C, 30 min at 481C, 5 min at 951C, and stopped by the addition of 10 nM ethylene diaminetetra acetic acid. qPCR was subsequently performed with the comparative quantitation method described in the protocol of Stratagene Mx3000P Real-Time PCR System (La Jolla, CA, USA). Using cDNA template obtained from the reverse transcription, non-multiplex PCR was performed in triplicates each with 1 ml 4 Â diluted cDNA product, 12.5 ml TaqMan Universal PCR Master Mix (Applied Biosystems) containing AmpliTaq Gold DNA polymerase, AmpErase UNG, dNTPs with dUTP, passive reference, optimized buffer components, 900 nM of each primer and 200 nM TaqMan probe in a total volume of 25 ml. The thermal cycling program consisted of 2 min at 501C for UNG activation and 10 min at 951C for polymerase activation, followed by 40 cycles each of 15 s at 951C plus 1 min at 601C. The threshold cycles (C T ) were calculated using the software in the Stratagene Mx3000P Real-Time PCR machine.
In the second method (CE), fluorescence-labeled PCR forward-primer targeting at Exon 9 and a reverseprimer targeting at Exon 11 of the long form of b 2 subunit (b 2L ) (NM_021911) ( Figure 1 ) were employed for both reverse transcription and PCR amplification in a single reaction tube. RT-PCR reactions were performed in a 25-ml mixture containing 1 Â RT buffer, 0.9 mM MnCl 2 , 200 mM of each dNTP, 750 nM reverse primers, 20 U RNase inhibitor, 5 U Thermus thermophilus (Tth) DNA polymerase (Roche, Basel, Switzerland) and 10 ng RNA sample. The mixture was incubated at 601C for 30 min before addition of the following reagents to a total volume of 80 ml: 0.75 nM ethylene glycol-bis (2-aminoethyl ether) (EGTA), 150 nM forward primers, and 1 Â PCR buffer. The final mixture was incubated at 941C for 1 min followed by 10 cycles each of denaturation at 941C for 30 s, annealing at 551C for 30 s and elongation at 721C for 45 s. Subsequently, an additional 25 cycles of denaturation, annealing and elongation were carried out; in each cycle, the elongation time was 5 s longer than the immediately preceding cycle. After these cycles, a prolonged elongation for 5 min at 721C was performed.
To measure RT-PCR products by means of CE, 1 ml aliquot of the RT-PCR post-reaction mix was diluted to 50 ml with ddH 2 O, 1 ml of which was added to 18.75 ml Hi-Deionized formamide and 0.25 ml of GeneScan-500 ROX size standard (Applied Biosystems). This mixture was denatured at 951C for 3 min before fractionation and characterization by CE using the ABI 3130 Genetic Analyzer equipped with a laser-induced fluorescence detector and Genemapper software. The length and quantity of each PCR product were determined, respectively, from its position and peak area. 36 The ratios of the long isoform of b 2 subunit over the short isoform (b 2L /b 2S ), and the long isoform over the sum of the two isoforms (b 2L /b 2T ) were subjected to statistical analysis.
Statistical analysis of GABRB2 mRNA expression SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) was employed for statistical analyses. 37 Multiple regression analyses were used to determine the contributions of demographic and clinical characteristics to the mRNA levels, and logistic regression used to determine the usefulness of expression parameters for the prediction of diagnostic status. 38 Differences between these two diagnostic groups in GABRB2 mRNA expression were subjected to analysis of covariance (ANCOVA) analyses with diagnostic status used as the independent variable and demographic parameters with notable effects on mRNA levels included as covariates. Statistical differences in demographic variables among the three genotypes were analyzed by ANCOVA, with genotype status as independent factor. Effects of genotype variations on gene expression were examined using analysis of variance with genotype as independent variable. Covariate analysis was used in the case of demographic parameters with notable effects on gene expression.
Population genetics analysis
Genotyping data were obtained and subjected to population genetics analysis. The Hardy-Weinberg (HW) exact test from Genepop V3.4 website was employed to examine HW equilibrium in both the control and schizophrenia groups using the default parameter values. Pairwise linkage disequilibrium (LD) among the SNPs was calculated for the control group with the COCAPHASE module of UN-PHASED, 39 and visualized by custom-made BASH shell scripts, which will be available at request. SNPs highly correlated with each other were grouped into LD bins. To reduce computational workload and enhance information content, tagging SNPs were selected with a threshold of logarithm of odds at 3.0 and r 2 at 0.8 employing the Tagger program 40 in Haploview version 3.2. 41 These tagging SNPs were used to represent all the SNPs in the same SNP bins in disease association analysis, genotypical correlation analyses by ANCOVA and quantitative trait association analysis.
Quantitative trait analysis of association between SNPs and GABRB2 mRNA expression Quantitative trait association analysis was implemented by means of the QTPHASE module of the UNPHASED V2.404 package 39 for alleles of tagging SNPs and tagging SNP haplotypes. Data from both the control (N = 31) and schizophrenic (N = 31) cohorts were included. The UNPHASED program employed the expectation maximization algorithm to infer uncertain haplotypes. In the likelihood ratio test, 42 alleles of SNPs and haplotypes were assumed to exert only additive effects on quantitative traits, and their correlations with expressions of the mRNA transcripts were analyzed using a generalized linear model. 39 Only alleles and haplotypes with a frequency no less than 5% were analyzed. Bonferroni correction for multiple testing was applied to the likelihood ratio test of association with a correction factor derived from the degree of freedom (df). Alleles of tagging SNPs and tagging SNP haplotypes that were significant in the likelihood ratio test (P < 0.05 for alleles and P corr < 0.05 for haplotypes) were evaluated further with a permutation procedure implemented by QTPHASE. 39 In the permutation, the global null hypothesis tested was that all odds ratios were equal. One thousand rounds of permutations were performed in each analysis, and in every round some of the quantitative trait values in the original data set were randomly reassigned among the subjects. Disease association analysis was performed with COCAPHASE module of the UNPHASED V2.404 package.
Cloning of GABA A receptor subunits
The human GABA A receptor a 1 , b 2S and g 2L subunit cDNAs were amplified from human brain cDNA library (Resgen, Invitrogen, Carlsbad, CA, USA) using the primers shown in Supplementary Table 1 , and individually cloned into the mammalian expression vector pcDNA3.1 giving, respectively, pcDNA3.1-a 1 , pcDNA3.1-b 2S and pcDNA3.1-g 2L . To yield pcDNA3.1-b 2L , a 236-bp fragment of b 2L cDNA including 114 bp of Exon 10 was amplified from the library and digested by ApaI and XhoI, utilizing their unique intrinsic restriction sites in the fragment. The resultant sticky-end fragment of 221/229 bp was subcloned into pcDNA3.1-b 2S to yield the pcDNA3.1-b 2L construct. The fidelity of the final expression constructs was verified by DNA sequencing. 2L , using the Genejuice transfection reagent (Novagen, Darmstadt, Germany). Whole-cell patch-clamp recordings were carried out on the cells using an EPC9 amplifier (HEKA, Germany) 36-60 h after transfection. Cells were voltage-clamped at À60 mV. Pipette-to-bath resistance was 3.0-6.0 MO when filled with the internal solution containing 140 mM CsCl, 1 mM MgCl 2 , 11 mM EGTA, 4 mM Mg 2 þ -ATP and 10 mM N-2-hydroxyl piperazine-N 0 -2-ethane sulfonic acid (HEPES), adjusted to pH 7.3 with CsOH. In the GABA current rundown experiments, Mg 2 þ -ATP was excluded from the internal solution. The external superfusion solution contained 150 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 and 10 mM HEPES, adjusted to pH 7.2 with NaOH. 43 The cells were constantly perfused with the external solution at 5 ml/min.
GABA dose-current relationship GABA was dissolved in the external solution, and applied to the cell by gravity flow. GABA dosecurrent responses were measured at 0.3-300 mM GABA as described. 43 The data were fitted to a Hill equation to estimate half-maximal concentration (EC 50 ) and Hill coefficient (n H ). The results were obtained from 25 to 27 cells gathered from 12 independent transfections, and presented in mean7standard error.
GABA-potentiated current rundown
Repetitive applications of GABA (100 or 300 mM, 5-s duration, 60-s interval) to induce GABA current rundown was initiated when the cells were found to display consistent responses to low concentrations of GABA (10 mM, 3-min interval). 44 The 30 consecutive whole-cell responses to the repetitive applications were evaluated in terms of the observed peak current as a percentile of the initial peak current. The results obtained from 8-12 cells gathered from six independent transfections were presented in mean7standard error. Two-tailed Student's t-test was employed for statistical calculation of differences between receptors containing b 2L and those containing b 2S .
Results

Standardization and normalization of qPCR
Quantitation of mRNA by qPCR was performed with TaqMan probes targeting at the junction of Exons 9 and 10 on the mRNA for the short isoform b 2S (NM_000813), at the junction of Exons 10 and 11 for the long isoform b 2L (NM_021911), or at the junction of Exons 2 and 3 for the total sum of the two isoforms b 2T (NM_000813 and NM_021911) (Figure 1 ).
To estimate amplification efficiency, standard curves for each set of primers and probes used to measure b 2S , b 2L , b 2T , and the reference genes GAPDH, UBC and HMBS were established by plotting the C T values obtained at varying amounts of cDNA templates estimated from the amount of RNA employed in the preceding reverse transcription step. Each individual amplification efficiency was estimated from the slope of the corresponding standard curve by means of the formula E = [10 (À1/slope) ]À1, and employed to correct the amplified amounts of b 2S , b 2L, b 2T , GAPDH, UBC and HMBS in accordance to the manufacturer's recommendation. The estimated amplification efficiencies were 101% for b 2L , 99.7% for b 2S , 100.9% for b 2T , 99.0% for GAPDH, 99.5% for UBC and 100.5% for HMBS.
The expression level of GABRB2 was determined from C T values obtained from qPCR with the following two corrections. First, batch-to-batch experimental variations were corrected by the inclusion of a calibrator RNA in each batch of assay. Secondly, variations in sample quality were normalized by a normalization factor (NF), which is the geometric mean of mRNA measurements of the three reference genes GAPDH, HMBS and UBC. 45 The estimated values of b 2L , b 2S and b 2T before and after normalization with NF, and the calculated b 2L /b 2S and b 2L /b 2T ratios, were subjected to statistical analysis.
Effects of demographic and clinical characteristics on mRNA levels
To assess the effects of demographic and diagnostic variables on the levels of GABRB2 mRNA for a cohort, forward stepwise multiple regression analyses were performed using diagnostic status, age, gender, pH, postmortem interval, duration of refrigerator storage of sample (RFI) and smoking status at time of death as independent variables. For the schizophrenia group, age of onset, duration of illness and lifetime of antipsychotic exposure in terms of fluphenazine equivalent in grams were also included as independent variables.
With combined patient and control cohort (n = 62), the analyses showed that the three GABRB2 mRNA measurements, b 2L , b 2S and b 2T , were inversely correlated with RFI (P < 0.01) before normalization. Therefore, RFI was included as a covariate in diseaseexpression correlation analysis, even though no correlation was found between the three GABRB2 mRNA measurements and any demographic parameters after normalization with NF. There were significant inverse correlations as well between RFI and measurements of the reference genes GAPDH, HMBS, as well as their geometric mean NF (Table 2 ).
In the same patient-control cohort, RFI was found to be inversely correlated with b 2L /b 2S ratio based on CE measurements. Therefore, RFI was used as a covariate in subsequent disease-b 2L /b 2S ratio correlation analysis. The b 2L /b 2T ratio was found to be correlated with age based on qPCR, and also correlated with gender based on CE. Accordingly single-covariate analysis with age was included for the qPCR measurements, and single-covariate analysis with gender was included for the CE measurements. As well, double-covariate (age and
analysis was performed for disease-b 2L /b 2T ratio correlations based on all measurements using both methods. With respect to the effects of clinical parameters in the patient cohort (n = 31), there were significant contributions from age of onset to b 2S and b 2T , but not to b 2L measurements before normalization. After normalization with NF, no correlation was found between the three GABRB2 mRNA measurements and any clinical parameters. Nevertheless, b 2L /b 2S and b 2L / b 2T ratios measured by CE were inversely correlated with lifetime of antipsychotics exposure in terms of fluphenazine equivalent in grams, and b 2L /b 2T measured by qPCR was inversely correlated with duration of illness. Furthermore, there was no correlation between the clinical parameters and any one of the three reference genes or NF (Table 2) .
Decreases in b 2L , b 2S and b 2T mRNA Statistical analysis was performed on qPCR measurements of b 2L , b 2S and b 2T mRNA after normalization with NF (Figure 2a and b) , and without any covariate to give P-value as well as with RFI as a covariate to give P covariate . It was shown that the long isoform b 2L mRNA level was markedly reduced in schizophrenia (decreased by 21.7%; F(1, 60) = 9.7, P = 0.003; F(1, 59) = 9.4, P covariate = 0.003). The short isoform b 2S mRNA was also significantly reduced in schizophrenia (decreased by 13.4%; F(1, 60) = 4.9, P = 0.032; F(1, 59) = 4.6, P covariate = 0.035). The total b 2T mRNA level was likewise reduced in schizophrenia (decreased by 15.8%; F(1, 60) = 5.5, P = 0.022; F(1, 59) = 5.3, P covariate = 0.025) (Figure 2a ). When the males were analyzed in separation from the females, even larger reductions in expression were observed in the schizophrenic cohort: b 2L decreased by 24.3% (F(1, 45) = 10.7, P = 0.002; F(1, 44) = 10.4, P covariate = 0.002), b 2S decreased by 18.5% (F(1, 45) = 7.8, P = 0.008; F(1, 44) = 7.6, P covariate = 0.009) and b 2T decreased by 21.1% (F(1, 45) = 10.0, P = 0.003; F(1, 44) = 9.7, P covariate = 0.003) (Figure 2b ). There were no significant differences between schizophrenia and control cohorts with respect to the reference genes GAPDH, HMBS and UBC, or their geometric mean NF (F < 3.5; P > 0.05 with or without RFI as a covariate).
Forward stepwise conditional logistic regression analysis performed with b 2L , b 2S and b 2T as covariates demonstrated that the mRNA level of b 2L was a useful potential predictor for diagnostic status, achieving 67.7% correct prediction based on un-normalized mRNA measurements (w 2 = 9.3; P = 0.002), and 66.1% using data normalized with NF (w 2 = 9.3; P = 0.002). Two isoforms of GABRB2 in schizophrenia C Zhao et al Forward stepwise conditional logistic regression analysis suggested that b 2L /b 2S is a useful parameter for the prediction of diagnostic status, with 67.7% correct identification of diagnostic class using data from qPCR (w 2 = 7.2; P = 0.007) and 54.8% correct identification using data from CE (w 2 = 5.5; P = 0.020).
Selection of tagging SNPs for quantitative trait and ANCOVA analysis
A total of 16 SNPs (rs187269, or S1; rs252944, S2; ss48400077, S3; rs194072, S4; ss48400076, S5; ss48400075, S6; rs13178374, S7; ss48400074, S8; rs10060079, S9; ss48400073, S10; rs2546620, S11; rs2617505, S12; rs10060148, S13; rs1816072, S14; rs1816071, S15; rs6556547, S16; Table 3 ) within a 3.89-kb genomic region spanning Intron 8, Exon 9 and Intron 9 of GABRB2 were genotyped. The minor allele frequencies of the SNPs were between 0.06 and 0.40. HW equilibria for all the SNPs were analyzed in both the schizophrenia and control groups, and none of the SNPs showed any significant deviation (Supplementary Table 2 ). Disease association analysis was performed for all the SNPs and two SNP haplotypes, and significant results were obtained with S7, S14 and S15 in males (Supplementary Table 3 ). The SNPs S3, S5, S6, S8, S9, S10 and S13, with low minor allele frequencies ( < 0.05), were not included in further analyses. LD in the control group was assessed by pairwise D 0 and r 2 (Table 3) . LD bins were identified and seven SNPs were selected as tagging SNPs; six of them were selected based on the Tagger program, whereas S15 was employed in a previous study. 1 These seven tagging SNPs were subjected to quantitative trait association analysis regarding the relationship between GABRB2 expression and the various alleles, genotypes and haplotypes.
Allele and haplotype effects on GABRB2 mRNA levels by quantitative trait analysis Quantitative trait association analysis was performed with QTPHASE to determine whether normalized Two isoforms of GABRB2 in schizophrenia C Zhao et al GABRB2 expression measurements were correlated with alleles and haplotypes of the selected tagging SNPs in the combined patient-control cohort. The results indicated that the minor alleles of S1, S11, S14 and S15 were significantly correlated with reduced expression of b 2S , and minor alleles of S15 were significantly correlated with reduced expression of b 2L (Table 4) . When the males were analyzed in separation from the females, the minor alleles of S1, S14 and S15 remained correlated with reduced expression of b 2S , and minor alleles of S14 and S15 were significantly correlated with reduced expression of b 2L and b 2T (Table 4 ). In addition, 10 tagging-SNP haplotypes were significantly correlated with the expression of b 2S , among which the S14-S15 haplotype was also correlated with the expression of b 2L and b 2T (Table 5 ).
Genotypical and diagnostic effects on GABRB2 expression
One-way ANCOVA analysis was performed to evaluate the correlations between genotypes or diagnosis and GABRB2 expression, in which genotype or diagnosis was treated as independent factor, normalized mRNA measurements as dependent variables and RFI as a covariate. When overall genotypical effects were assessed on combined case and control samples of males and females, significant effects of S1 (P = 0.012), S2 (P = 0.018), S11 (P = 0.024), S14 (P = 0.022) and S15 (P = 0.009) were found on b 2S expression; marginal effects of S1 (P = 0.058), S2 (P = 0.050), S14 (P = 0.103) and S15 (P = 0.079) on b 2L ; marginal effects of S2 (P = 0.069) and S11 (P = 0.073) on b 2T (Figure 3) . When the males were analyzed in separation from the females, significant effects on b 2S expression (F(1, 43) = 3.9; P = 0.027), and marginal effects on b 2L (F(1, 43) = 2.4; P = 0.102) and b 2T (F(1, 43) = 2.8; P = 0.073) were found for S14 and S15 (Figure 3 ). ANCOVA analysis indicated that there was no significant correlation of any demographic variable with the three possible genotypes at S1, S2, S11, S14 or S15 (P > 0.05).
Post hoc analysis for effects on expression by individual genotypes was further performed within ( Figure 4) and between (Supplementary Figure 1) diagnostic groups. Intradiagnostic comparison indicated that, in the schizophrenic male cohort, individuals with heterozygous genotype of S14 or S15 showed significantly lower expression of b 2L (P = 0.030; Figure 4a ), b 2S (P = 0.047; Figure 4b ) and b 2T (P = 0.002; Figure 4c ) compared to the homozygous-major; and individuals with homozygous-minor genotype of S14 or S15 (P = 0.045), or heterozygous genotype of S11 (P = 0.041) showed significantly lower expression of b 2T compared to the homozygous-major. In interdiagnostic group comparison, it Two isoforms of GABRB2 in schizophrenia C Zhao et al was demonstrated for the schizophrenic male cohort that reductions in b 2L were significantly correlated with homozygous-major S2, S7 or S16, heterozygous S1, S11, S14 or S15, and homozygous-minor S14 or S15 (Supplementary Figure 1a) ; reductions in b 2S were significantly correlated with homozygous-major S2 or S7, as well as heterozygous S11, S14 or S15 (Supplementary Figure 1b) ; reductions in b 2T were significantly correlated with homozygous-major S2, S7 or S16, as well as heterozygous S1, S2, S11, S14 or S15 (Supplementary Figure 1c) . 44 the long isoform-containing receptors underwent a greater decrease in current amplitude than those containing the short isoform at either 100 mM GABA (decreasing to 5175% for a 1 b 2S g 2L , but only to 3874% for a 1 b 2L g 2L ; Figure 5a and b), or at 300 mM GABA (decreasing to 3674% for a 1 b 2S g 2L , but only to 2173% for a 1 b 2L g 2L ; Figure 5c and d).
Discussion
Disorders in GABAergic transmission are implicated in schizophrenia etiology, and genetic analyses point to a number of genes of the GABAergic pathway as candidate genes of the disease.
1,2 For the GABA A receptor b 2 subunit gene, GABRB2, positive association of SNPs and haplotypes with schizophrenia has been established for different human populations, 1, 2, [18] [19] [20] but the functional basis for the association has remained unidentified. As Exon 10, located downstream to the cluster of disease-associated SNPs in introns 8 and 9, is alternatively spliced to yield long and short isoforms of b 2 subunit mRNA transcripts, the relationships between the disease-associated SNPs and the relative expression of the two b 2 isoforms in schizophrenic brains need to be examined.
Based on measurements of GABRB2 mRNAs, the expressions of GABRB2 isoforms were found to be altered in the DLPFC of postmortem schizophrenic brains. Specifically, there were significant decreases in b 2L , b 2S and b 2T mRNA levels ( Two isoforms of GABRB2 in schizophrenia C Zhao et al suggest that both the expression and the alternative splicing of GABRB2 mRNA are affected in schizophrenics, thereby providing a plausible mechanism to bring about the observed association of SNPs and haplotypes in GABRB2 introns 8 and 9 with schizophrenia. In any event, the altered splicing of GABRB2 suggested by the present study, together with the altered splicing of GABA A receptor g 2 subunit mRNA previously observed in the prefrontal cortex of Figure 4 Effects of individual genotypes on GABRB2 expressions in male control and schizophrenic groups. Expression levels of b 2L (a), b 2S (b) and b 2T (c) are shown for S11, S14 and S15. Mean expressions are shown in columns (black = homozygous-major; white = heterozygous; gray = homozygous-minor) with standard error indicated by bars. The number of subjects in each genotype group is indicated on the corresponding column. *Denotes the homozygousmajor genotype being significantly different (P < 0.05) from the heterozygous genotype and marginally different (P = 0.05 in the case of both S14 and S15) from the homozygous-minor. **Denotes the homozygous-major genotype being significantly different (P < 0.05) from both the heterozygous and the homozygous-minor. Figure 3 Overall genotypic effects on GABRB2 expression in schizophrenics and controls. Expression levels of b 2L (a), b 2S (b) and b 2T (c) are shown for each genotype of S1, S2, S11, S14 and S15. Mean expressions are shown in columns (black = homozygous-major; white = heterozygous; gray = homozygous-minor) with standard error indicated by bars. # refers to genotype groups having only one subject, and therefore without standard error bar. *Denotes the homozygous-minor genotype being significantly different (P < 0.05) from the homozygous-major. **Denotes the homozygous-minor genotype being significantly different (P < 0.05) from both the homozygous-major and the heterozygous.
Two isoforms of GABRB2 in schizophrenia C Zhao et al schizophrenics, 28 point to the potential significance of GABA A receptor subunit isoforms in the disease.
The correlation between GABRB2 sequence polymorphisms and the levels of GABA A receptor b 2 subunit isoforms in postmortem brain samples was examined with respect to their genotypes, alleles and haplotypes. Both SNP-disease association (Supplementary Table 3 ) and genotype-expression association ( Figures 3 and 4) analyses demonstrated the importance of S14 and S15 in the male schizophrenia cohort. At these two SNPs, the homozygous-minor and heterozygous genotypes were overrepresented in male schizophrenics, and showed significantly reduced mRNA expression of b 2S , b 2L and b 2T relative to the homozygous-major. Whether the minor alleles of S14 and S15 could, in fact, be risk alleles for the disease across other population samples, such that they can be used to predict reduced expression of GABRB2, would need to be further studied. Quantitative trait analyses of the alleles (Table 4) and haplotypes (Table 5) were consistent with the genotype analyses (Figure 4) , showing that S14 and S15 were significant at allele and haplotype levels; and minor alleles were correlated with lower expression than major alleles.
GABA-potentiated current rundown, characterized by a decline in current amplitude, occurs when GABA A receptors are subjected to extended activation by repeated GABA applications. 44, 46, 47 Such GABA A receptor rundown, which can be rescued by intracellular infusions of ATP and phosphatase inhibitors, is likely related to the phosphorylation status of the receptor. 44, 47 As the potential phosphorylation site Thr 365 is present in b 2L but absent from b 2S , 24 the greater current rundown of a 1 b 2L g 2L receptors containing b 2L compared to a 1 b 2S g 2L receptors containing b 2S ( Figure 5 ) could stem from a deficient phosphorylation of a 1 b 2L g 2L upon depletion of ATP supply caused by repetitive GABA activation. Physiologically, dissimilar effects of ATP depletion on b 2L -containing and b 2S -containing GABA A receptors could be important, because phosphorylation constitutes one of the basic Figure 5 GABA-potentiated current rundowns of GABA A receptors containing either the long or the short b 2 isoform. The measured currents at successive additions of GABA over 30 min are expressed as a percentile of the peak current (D) of the initial response to 100 mM (part a) or 300 mM (part c). The data points represent average7standard error recorded from 8 to 12 cells from at least six independent transfections. Responses that were significantly different between the a 1 b 2S g 2L (') and a 1 b 2L g 2L (J) receptors based on the t-test are marked by asterisks (*P < 0.05; **P < 0.01). Single-cell responses to the 1st, 2nd, 5th, 10th, 20th and 30th applications of GABA are exemplified in part b for additions of 100 mM GABA, and in part d for additions of 300 mM GABA. regulatory mechanisms of GABA A function. 44, 47, 48 A rundown of GABA A receptors also has been suggested to be a dysfunction in human drug-resistant mesial temporal lobe epilepsy. 49 In conclusion, the present study has yielded a continuous chain of correlations between the GABRB2 genotypes and schizophrenia. Firstly, the expressions of the two alternatively spliced isoforms, b 2L and b 2S , were correlated with SNPs and haplotypes, some of which have been found earlier to be positively associated with schizophrenia 1 (Tables 4  and 5 , Figures 3 and 4) . Secondly, occurrence of alterations in both expression and alternative splicing was indicated in postmortem schizophrenic brains (Figure 2) . Thirdly, GABA A receptors containing b 2L displayed a more pronounced current rundown than receptors containing b 2S ( Figure 5 ). Altogether, these findings suggest that SNPs and haplotypes associated with schizophrenia could alter the expression of GABRB2 isoforms, giving rise to changes in the abundance of receptors containing b 2L relative to those containing b 2S in schizophrenic brains. As these two kinds of GABA A receptors are endowed with different functional characteristics as exhibited in current rundown, the resultant electrophysiological alterations could contribute to schizophrenia pathogenesis. So far such a causal chain of linkages leading from genotypes to electrophysiology has not yet been identified for any other candidate genes for schizophrenia. For the GABRB2 gene, further studies with enlarged sample sizes would be needed to validate the chain of correlations observed in the present study.
Although the correlations between disease-genotype, genotype-expression, expression-disease and isoform-electrophysiology identified in the present study could constitute important mechanistic components in schizophrenia pathogenesis, it is not ruled out that there might be additional genotype-disease relationships mediated by this gene. The nature of the interactions between these mechanistic components with other genotypic determinants of schizophrenia to produce the pathophysiological changes underlying this multigene disorder also awaits elucidation.
